Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (Weighted Average): 2010-2024

Historic Shares Outstanding (Weighted Average) for Fortress Biotech (FBIO) over the last 15 years, with Dec 2024 value amounting to $27.6 million.

  • Fortress Biotech's Shares Outstanding (Weighted Average) rose 30.42% to $29.8 million in Q3 2025 from the same period last year, while for Jun 2025 it was $29.6 million, marking a year-over-year increase of 48.47%. This contributed to the annual value of $27.6 million for FY2024, which is 208.69% up from last year.
  • Fortress Biotech's Shares Outstanding (Weighted Average) amounted to $27.6 million in FY2024, which was up 208.69% from $8.9 million recorded in FY2023.
  • Fortress Biotech's 5-year Shares Outstanding (Weighted Average) high stood at $27.6 million for FY2024, and its period low was $6.2 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $14.6 million, with a median of $8.9 million in 2023.
  • Data for Fortress Biotech's Shares Outstanding (Weighted Average) shows a peak YoY surged of 208.69% (in 2024) over the last 5 years.
  • Over the past 5 years, Fortress Biotech's Shares Outstanding (Weighted Average) (Yearly) stood at $6.2 million in 2020, then grew by 6.32% to $6.6 million in 2021, then grew by 9.02% to $7.2 million in 2022, then rose by 23.50% to $8.9 million in 2023, then spiked by 208.69% to $27.6 million in 2024.